The Future Of OTCs: Self-Selection Meets Diagnostics, Genetic Personalization
This article was originally published in The Tan Sheet
The next generation of consumer health products, including Rx-to-OTC switch opportunities, may work in concert with cutting-edge diagnostic tools and elements of personalized medicine, says Andrew Fish.
You may also be interested in...
Facilitating switch is CHPA’s top priority
Medagate Corp.’s payment technology that simplifies insurance reimbursement for OTCs could help level the playing field with competing prescription products.
A draft guidance on designing self-selection studies in support of Rx-to-OTC switches reflects FDA’s interest in drilling down for greater insight into consumers’ thought processes.